Home News Insights Trading halts Paper trading Guide Community My account

Market calendarNext market opening

Display in USD

Loading news article.

U.S. stock guide
Scanner guide
Paper trading guide
Terms of service
Privacy policy
Announcements
FAQ

Support: help@wapeb.comPartnerships: partnership@wapeb.com

WAPE is a free research, analysis and paper trading service. It does not place real securities orders. Market data and AI summaries are for information only, not investment advice or stock recommendations. Information may include delays, errors or estimates. Check original sources and supporting materials. You are responsible for your investment decisions and any resulting gains or losses.

Language한국어 English

Loading news article.

60 Degrees Pharmaceuticals Announces Clinical Improvement and Negative PCR Results in All Completed Expanded Access Babesiosis Study Patients | WAPE

Back All news

NewsGlobeNewswire

60 Degrees Pharmaceuticals Announces Clinical Improvement and Negative PCR Results in All Completed Expanded Access Babesiosis Study Patients

Oct 27, 2026, 08:06 ET · Published

View source

Article summary

60 Degrees Pharma reports clinical improvement and negative conventional PCR results in all five completed expanded access babesiosis study patients.

An excerpt from the original article.

Related companies

60 Degrees Pharmaceuticals, Inc. Common StockSXTPView stock

60 Degrees Pharmaceuticals, Inc. WarrantSXTPWView stock

60 Degrees Pharmaceuticals Announces Clinical Improvement and Negative PCR Results in All Completed Expanded Access Babesiosis Study Patients

Article summary

Related companies

Analyzed by WAPE AI.

Comments —